Wolfgang Kruis, Professor
Evang. Krankenhaus Kalk, Medical Department · Evangelisches Krankenhaus Kalk, Köln · Evang. Krankenhaus Kalk, Medical department
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wolfgang Kruis, Professor as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01966783 · Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative ProctitisDr. Falk Pharma GmbH · completed · Proctitis · principal investigator
- Ph3NCT01541579 · Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's DiseaseTigenix S.A.U. · completed · Crohn's Disease · principal investigator
- Ph3NCT01038739 · Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of DiverticulitisDr. Falk Pharma GmbH · terminated · Diverticulitis · principal investigator
- Ph3NCT00695643 · Mesalazine Granules vs. Placebo for the Prevention of Recurrence of DiverticulitisDr. Falk Pharma GmbH · terminated · Diverticulitis · principal investigator
- Ph3NCT00449722 · OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative ColitisDr. Falk Pharma GmbH · completed · Ulcerative Colitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.